Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 9876 - 9900 of 14692 in total
Iberdomide (CC-220) has been used in trials studying the treatment of Systemic Lupus Erythematosus.
Investigational
Experimental
AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.
Investigational
Matched Description: … AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's …
Dtp348 has been used in trials studying the treatment of Solid Tumors and Head and Neck Neoplasms.
Investigational
Matched Description: … Dtp348 has been used in trials studying the treatment of Solid Tumors and Head and Neck Neoplasms. …
Tedisamil (planned trade name Pulzium) is an investigational drug for atrial fibrillation and atrial flutter. It is currently being developed by Solvay and is currently under regulatory review by the United States Food and Drug Administration.
Investigational
Matched Description: … Food and Drug Administration. ... Tedisamil (planned trade name Pulzium) is an investigational drug for atrial fibrillation and atrial ... It is currently being developed by Solvay and is currently under regulatory review by the United States …
A sulfhydryl reagent that is widely used in experimental biochemical studies. [PubChem]
Experimental
Matched Categories: … Indicators and Reagents …
Baloxavir is under investigation in clinical trial NCT04327791 (Combination Therapy With Baloxavir and Oseltamavir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)).
Investigational
Matched Description: … Baloxavir is under investigation in clinical trial NCT04327791 (Combination Therapy With Baloxavir and
Matched Categories: … Baloxavir and prodrugs …
Investigational
Matched Categories: … Diet, Food, and Nutrition …
Bupranolol is a non-selective beta blocker with potency similar to propanolol. It does not have intrinsic sympathomimetic activity (ISA), but does have strong membrane stabilizing activity.
Experimental
Dichloroisoproterenol has been used in trials studying the treatment and basic science of Insulin Resistance and Polycystic Ovary Syndrome.
Investigational
Matched Description: … and Polycystic Ovary Syndrome. ... Dichloroisoproterenol has been used in trials studying the treatment and basic science of Insulin Resistance …
Lerisetron has been used in trials studying the supportive care of Nausea and Vomiting and Testicular Germ Cell Tumor.
Investigational
Matched Description: … Lerisetron has been used in trials studying the supportive care of Nausea and Vomiting and Testicular …
Vet approved
Axt914 is under investigation in clinical trial NCT00417261 (Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.).
Investigational
Matched Description: … Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy ... Axt914 is under investigation in clinical trial NCT00417261 (Safety, Tolerability, Pharmacodynamic and
Brilacidin is under investigation for the supportive care of Mucositis, Stomatitis, Mouth Diseases, and Head and Neck Neoplasms.
Investigational
Matched Description: … Head and Neck Neoplasms. ... Brilacidin is under investigation for the supportive care of Mucositis, Stomatitis, Mouth Diseases, and
Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Experimental
Matched Description: … aberrations and cancers. ... Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome …
Trotabresib is an oral, potent, and reversible inhibitor of the epigenetic target bromodomain and extra-terminal (BET) proteins.
Investigational
Matched Description: … Trotabresib is an oral, potent, and reversible inhibitor of the epigenetic target bromodomain and extra-terminal …
XL999 has the potential to provide benefit to patients with lung cancer and acute myelogenous leukemia. XL999 is a new chemical entity that inhibits a spectrum of receptor tyrosine kinases (RTKs) with growth promoting and angiogenic properties, including FGFR 1/3, PDGFRα/β, VEGFR2/KDR, KIT, and FLT3. XL999 also inhibits FLT4 and...
Investigational
Matched Description: … XL999 also inhibits FLT4 and SRC. ... angiogenic properties, including FGFR 1/3, PDGFRα/β, VEGFR2/KDR, KIT, and FLT3. ... XL999 has the potential to provide benefit to patients with lung cancer and acute myelogenous leukemia …
Muraglitazar (Bristol-Myers Squibb/Merck) is a new agent under investigation for the treatment of patients with type 2 diabetes. It belongs to a novel class of drugs that target the peroxisome proliferator-activated receptors, both alpha and gamma subtypes. In addition to improvements in blood glucose and hemoglobin A1c (HbA1c), muraglitazar treatment...
Investigational
Matched Description: … with a substantial reduction in triglycerides (TGs), an increase in HDL-C, and a modest decrease in ... belongs to a novel class of drugs that target the peroxisome proliferator-activated receptors, both alpha and ... In addition to improvements in blood glucose and hemoglobin A1c (HbA1c), muraglitazar treatment is associated …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Peficitinib has been used in trials studying the treatment and basic science of Psoriasis, Pharmacodynamics, Drug Interactions, Colitis, Ulcerative, and RHEUMATOID ARTHRITIS, among others.
Investigational
Matched Description: … , Drug Interactions, Colitis, Ulcerative, and RHEUMATOID ARTHRITIS, among others. ... Peficitinib has been used in trials studying the treatment and basic science of Psoriasis, Pharmacodynamics …
Matched Categories: … Antineoplastic and Immunomodulating Agents …
Displaying drugs 9876 - 9900 of 14692 in total